{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T05:23:20Z","timestamp":1768281800100,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s12328-022-01653-1","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T05:14:42Z","timestamp":1657775682000},"page":"924-928","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Two cases of ulcerative colitis that developed while using abatacept"],"prefix":"10.1007","volume":"15","author":[{"given":"Takeshi","family":"Takasago","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0569-2371","authenticated-orcid":false,"given":"Ryohei","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Oka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Norii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Iwahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumio","family":"Shimamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,14]]},"reference":[{"key":"1653_CR1","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMra1102942","volume":"365","author":"S Danese","year":"2011","unstructured":"Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med. 2011;365:1713\u201325.","journal-title":"N Engl J Med"},{"key":"1653_CR2","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/S0140-6736(12)60150-0","volume":"380","author":"I Ord\u00e1s","year":"2012","unstructured":"Ord\u00e1s I, Eckmann L, Talamini M, et al. Ulcerative colitis. Lancet. 2012;380:1606\u201319 (London, England).","journal-title":"Lancet"},{"key":"1653_CR3","doi-asserted-by":"publisher","first-page":"294","DOI":"10.12688\/f1000research.20805.1","volume":"9","author":"RJ Porter","year":"2020","unstructured":"Porter RJ, Kalla R, Ho GT. Ulcerative colitis recent advances in the understanding of disease pathogenesis. F1000Research. 2020;9:294.","journal-title":"F1000Research"},{"key":"1653_CR4","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1742-7843.2009.00375.x","volume":"104","author":"R Korhonen","year":"2009","unstructured":"Korhonen R, Moilanen E. Abatacept, a novel CD80\/86-CD28 T cell co-stimulation modulator, in the treatment of rheumatoid arthritis. Basic Clin Pharmacol Toxicol. 2009;104:276\u201384.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1653_CR5","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1136\/gut.2006.095539","volume":"55","author":"LM Amezcua-Guerra","year":"2006","unstructured":"Amezcua-Guerra LM, Hern\u00e1ndez-Mart\u00ednez B, Pineda C, et al. Ulcerative colitis during CTLA-4Ig therapy in a patient with rheumatoid arthritis. Gut. 2006;55:1059\u201360.","journal-title":"Gut"},{"key":"1653_CR6","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.3109\/00365521.2014.946087","volume":"49","author":"R Motohashi","year":"2014","unstructured":"Motohashi R, Ikeuchi H, Hiromura K, et al. Two cases of ulcerative colitis developing in rheumatoid arthritis patients during abatacept therapy. Scand J Gastroenterol. 2014;49:1270\u20131.","journal-title":"Scand J Gastroenterol"},{"issue":"62\u20139","key":"1653_CR7","volume":"143","author":"WJ Sandborn","year":"2012","unstructured":"Sandborn WJ, Colombel JF, Sands BE, et al. Abatacept for crohn\u2019s disease and ulcerative colitis. Gastroenterology. 2012;143(62\u20139): e4.","journal-title":"Gastroenterology"},{"key":"1653_CR8","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.4049\/jimmunol.171.7.3348","volume":"171","author":"Q Tang","year":"2003","unstructured":"Tang Q, Henriksen KJ, Boden EK, et al. Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells. J Immunol. 2003;171:3348\u201352.","journal-title":"J Immunol"},{"key":"1653_CR9","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/rheumatology\/kex012","volume":"57","author":"S Nakayamada","year":"2018","unstructured":"Nakayamada S, Kubo S, Yoshikawa M, et al. Differential effects of biological DMARDs on peripheral immune cell phenotypes in patients with rheumatoid arthritis. Rheumatology. 2018;57:164\u201374.","journal-title":"Rheumatology"},{"key":"1653_CR10","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0092-8674(00)80856-9","volume":"101","author":"S Sakaguchi","year":"2000","unstructured":"Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell. 2000;101:455\u20138.","journal-title":"Cell"},{"key":"1653_CR11","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s10620-010-1286-2","volume":"56","author":"H Ogino","year":"2011","unstructured":"Ogino H, Nakamura K, Ihara E, et al. CD4+CD25+ regulatory T cells suppress Th17-responses in an experimental colitis model. Dig Dis Sci. 2011;56:376\u201386.","journal-title":"Dig Dis Sci"},{"key":"1653_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005087","volume":"4","author":"S Bouguermouh","year":"2009","unstructured":"Bouguermouh S, Fortin G, Baba N, et al. CD28 co-stimulation down regulates Th17 development. PLoS ONE. 2009;4: e5087.","journal-title":"PLoS ONE"},{"key":"1653_CR13","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/ibd\/izy395","volume":"25","author":"K Fukaura","year":"2019","unstructured":"Fukaura K, Iboshi Y, Ogino H, et al. Mucosal profiles of immune molecules related to T helper and regulatory T cells predict future relapse in patients with quiescent ulcerative colitis. Inflamm Bowel Dis. 2019;25:1019\u201327.","journal-title":"Inflamm Bowel Dis"},{"key":"1653_CR14","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1056\/NEJMoa1414428","volume":"372","author":"MA Postow","year":"2015","unstructured":"Postow MA, Chesney J, Pavlick AC, et al. Nivolumab and ipilimumab versus ipilimumab in untreated melanoma. N Engl J Med. 2015;372:2006\u201317.","journal-title":"N Engl J Med"},{"key":"1653_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa1504030","volume":"373","author":"J Larkin","year":"2015","unstructured":"Larkin J, Chiarion-Sileni V, Gonzalez R. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N Engl J Med. 2015;373:23\u201334.","journal-title":"N Engl J Med"},{"key":"1653_CR16","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1200\/JCO.2017.77.6385","volume":"36","author":"JR Brahmer","year":"2018","unstructured":"Brahmer JR, Lacchetti C, Schneider BJ, et al. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: american society of clinical oncology clinical practice guideline. J Clin Oncol. 2018;36:1714\u201368.","journal-title":"J Clin Oncol"},{"key":"1653_CR17","first-page":"e5695","volume":"11","author":"MG Attalla","year":"2019","unstructured":"Attalla MG, Singh SB, Khalid R, et al. Relationship between ulcerative colitis and rheumatoid arthritis: a review. Cureus. 2019;11:e5695.","journal-title":"Cureus"},{"key":"1653_CR18","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/ibd.20406","volume":"14","author":"R Cohen","year":"2008","unstructured":"Cohen R, Robinson D Jr, Paramore C, et al. Autoimmune disease concomitance among inflammatory bowel disease patients in the United States, 2001\u20132002. Inflamm Bowel Dis. 2008;14:738\u201343.","journal-title":"Inflamm Bowel Dis"},{"key":"1653_CR19","doi-asserted-by":"publisher","first-page":"6137","DOI":"10.3748\/wjg.v23.i33.6137","volume":"23","author":"ML Halling","year":"2017","unstructured":"Halling ML, Kjeldsen J, Knudsen T, et al. Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases. World J Gastroenterol. 2017;23:6137\u201346.","journal-title":"World J Gastroenterol"},{"key":"1653_CR20","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1093\/rheumatology\/keaa856","volume":"60","author":"L Tidblad","year":"2021","unstructured":"Tidblad L, Westerlind H, Delcoigne B, et al. Comorbidities at diagnosis of rheumatoid arthritis: a population-based case-control study. Rheumatology. 2021;60:3760\u20139.","journal-title":"Rheumatology"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-022-01653-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-022-01653-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-022-01653-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T13:34:06Z","timestamp":1664026446000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-022-01653-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,14]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1653"],"URL":"https:\/\/doi.org\/10.1007\/s12328-022-01653-1","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,14]]},"assertion":[{"value":"15 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human\/animal rights"}},{"value":"For this type of study, formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}